Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compounds and their use as therapeutically active substances in the treatment and/or reducing signs or symptoms of diseases involving the retinal pigment epithelium

Compounds and their use as therapeutically active substances in the treatment and/or reducing signs or symptoms of diseases involving the retinal pigment epithelium

US Patent 11541039 · Granted Jan 3, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

N-(4-(oxazol-5-yl)phenyl) chromane-3-carboxamide derivatives and related compoun2025
N-(4-(oxazol-5-yl)phenyl) chromane-3-carboxamide derivatives and related compoun2025
N-(4-(oxazol-5-yl)phenyl) chromane-3-carboxamide derivatives and related compoun2025
Antibodies specific for hyperphosphorylated tau and methods of use thereof2024
Combination treatments comprising administration of 1H-pyrazolo[4,3-B]pyridines2023
Compounds and their use as therapeutically active substances in the treatment an2023
Compounds and their use as therapeutically active substances in the treatment an2023
Compounds and their use as therapeutically active substances in the treatment an2023
Combination treatments comprising administration of 1H-pyrazolo[4,3-b]pyridines2023
Circuit arrangement, in particular for an electrically driven motor vehicle2023
Pyrazolo[3,4-B]pyridines and imidazo[1,5-B]pyridazines as PDE1 inhibitors2022
1H-pyrazolo[4,3-b]pyridines as PDE1 inhibitors2022